【Press Release】 Medikonia Appointed by Arima Genomics as an Exclusive Distributor in HK & Macau
Arima Genomics Adds Additional Distributors to Expand its Reach in Asia-Pacific Region
November 10, 2022—Arima Genomics, Inc., the leader in 3D genomics, today announced new agreements with two distributors in the Asia-Pacific region. The distributors will use Arima Genomics’ market-leading portfolio of 3D genomics tools to aid basic and translational researchers in driving discovery in genomics and improving human health. The two distributors selected to join Arima’s growing network are Medikonia and Custom Science Australia.
“There is cutting-edge research occurring across Asia and Australia that can benefit from Arima Genomics’ technologies for better understanding the three-dimensional structure of the genome,” said James Kane, Sales Manager for Arima Genomics. “These new distributor relationships will help Arima Genomics better serve these customers–helping them power discoveries in cancer, neuroscience, conservation biology, and more.”
Medikonia is a Hong Kong-based distributor of life science molecular reagents, equipment, and antibodies servicing Hong Kong and Macau. Medikonia supplies reagents to academic institutions and clinical labs across greater China focused on oncology, immunology, neurology, and cardiovascular research.
“We are honored to join the Arima Genomics network to enable our customers in Hong Kong and Macau to benefit from Arima Genomics’ 3D genomics technology,” said Joe Lai, CEO at Medikonia.